STAT — A decade of reporting from the frontiers of health and …
An authoritative database of FDA’s fast-tracked medical devices. STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.
About Us - STAT health, life science, medicine and biotech news
At STAT, our mission is to deliver trusted, tough-minded journalism on the business of making medicines, health tech, science, public health, hospitals, and insurance.
Latest health, science and medicine news from STAT
Latest Delivering must-read stories about health, medicine, and scientific discovery Biotech STAT Staff, Adam Feuerstein, Damian Garde, Katherine MacPhail, and Angus Chen
STAT Health - Science, medicine and healthcare news
Health, science, and medicine news for patients and practitioners: Latest developments on long Covid, breast cancer, opioids, abortion pills and more.
STAT+ Subscription | STAT
Our price covers the cost of daily coverage, two daily STAT+ newsletters, free access to exclusive subscriber only virtual events, discounts to STAT events and summits, and additional benefits.
STAT Biotech: Market-moving coverage of new drug development
Latest Biotech STAT Staff ‘Remarkable’ drug results against an aggressive leukemia Biotech Jonathan Wosen Cancer detection firm Freenome to go public via $330 million SPAC deal
STAT Events
STAT’s annual Monday evening event at JPM examines the political, social, and scientific forces reshaping health care in the year ahead.
STAT Pharma: The science and business of new drug development
STAT coverage and analysis of top pharmaceutical companies, from clinical trials to FDA approvals, from startups to Big Pharma mergers and acquisitions.
FDA claims Covid vaccine caused kids’ deaths. Experts are ... - STAT
Nov 29, 2025 · Many of the experts who STAT spoke with believed that Prasad had written the memo with the express purpose that it would be leaked.
FDA plans to require just a single clinical trial for new approvals
4 days ago · “You can achieve the same statistical power with one trial as you would with two trials when it’s designed and controlled appropriately,” Makary told STAT by phone.